Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Rigshospitalet, Denmark.
Recruitment status was  Recruiting
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: September 13, 2005
Last updated: October 18, 2006
Last verified: September 2005
The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Condition Intervention
Procedure: NovoSeven treatment according to guideline

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective

Resource links provided by NLM:

Further study details as provided by Rigshospitalet, Denmark:

Study Start Date: January 2000
Estimated Study Completion Date: December 2010

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Indication for NovoSeven treatment according to our guideline

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00192933

Contact: Pär Johansson, MD, MPA +45 3545 2030
Contact: Jakob Stensballe, MD +45 3545 8269

Rigshospitalet, Copenhagen University Hospital Recruiting
Copenhagen, Denmark, DK-2100
Contact: Pär Johansson, MD, MPA    +45 3545 2030   
Contact: Jakob Stensballe, MD    +45 3545 8269   
Sponsors and Collaborators
Rigshospitalet, Denmark
Study Chair: Pär Johansson, MD, MPA Blood Bank, Rigshospitalet, Copenhagen University Hospital
  More Information Identifier: NCT00192933     History of Changes
Other Study ID Numbers: 2004-41-3996 
Study First Received: September 13, 2005
Last Updated: October 18, 2006
Health Authority: Denmark: Ethics Committee

Additional relevant MeSH terms:
Pathologic Processes processed this record on October 21, 2016